Fieldpoint Private Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,450
Closed -$282K 76
2016
Q4
$282K Sell
2,450
-376
-13% -$43.4K 0.19% 64
2016
Q3
$334K Hold
2,826
0.22% 64
2016
Q2
$343K Hold
2,826
0.23% 63
2016
Q1
$317K Hold
2,826
0.22% 57
2015
Q4
$290K Sell
2,826
-380
-12% -$38.2K 0.2% 56
2015
Q3
$299K Hold
3,206
0.21% 58
2015
Q2
$312K Sell
3,206
-900
-22% -$90.1K 0.19% 59
2015
Q1
$413K Hold
4,106
0.25% 62
2014
Q4
$429K Hold
4,106
0.28% 61
2014
Q3
$438K Sell
4,106
-400
-9% -$41.5K 0.28% 64
2014
Q2
$471K Sell
4,506
-1,680
-27% -$170K 0.28% 66
2014
Q1
$608K Buy
6,186
+2,130
+53% +$197K 0.36% 65
2013
Q4
$371K Buy
4,056
+200
+5% +$18.4K 0.21% 64
2013
Q3
$334K Sell
3,856
-150
-4% -$13.5K 0.2% 65
2013
Q2
$344K Buy
+4,006
New +$340K 0.21% 60

Other funds holding JNJ

Fieldpoint Private Advisors's JNJ Position: Q1 2017 in Review

Fieldpoint Private Advisors sold out of Johnson & Johnson (JNJ) in Q1 2017, closing a stake of 2,450 shares — an estimated $282K sold.

Fieldpoint Private Advisors first reported a position in JNJ in Q2 2013 and held it in 15 quarters. The position peaked at $608K in Q1 2014. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q1 2017.

  • Fieldpoint Private Advisors reported no remaining Johnson & Johnson position as of Q1 2017 after selling out during the quarter.
  • Fieldpoint Private Advisors sold 2,450 Johnson & Johnson shares in Q1 2017, an estimated $282K.
  • Fieldpoint Private Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 15 quarters.
  • Fieldpoint Private Advisors's Johnson & Johnson position peaked at $608K in Q1 2014.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2017.

Based on Fieldpoint Private Advisors's 13F filing for Q1 2017, filed 24 Apr 2017.